: Lung cancer screening (LCS) by low-dose computed tomography is a strategy for secondary prevention of lung cancer. In the last two decades, LCS trials showed several options to practice secondary prevention in association with primary prevention, however, the translation from trial to practice is everything but simple. In 2020, the European Society of Radiology and European Respiratory Society published their joint statement paper on LCS. This commentary aims to provide the readership with detailed description about hurdles and potential solutions that could be encountered in the practice of LCS.
European lung cancer screening: valuable trial evidence for optimal practice implementation / Silva, Mario; Milanese, Gianluca; Ledda, Roberta E; Nayak, Sundeep M; Pastorino, Ugo; Sverzellati, Nicola. - In: BRITISH JOURNAL OF RADIOLOGY. - ISSN 0007-1285. - (2022), p. 20200260. [10.1259/bjr.20200260]
|Appare nelle tipologie:||1.1 Articolo su rivista|